Global properties of delayed-HIV dynamics models with differential drug efficacy in cocirculating target cells

From MaRDI portal
Publication:1664298

DOI10.1016/j.amc.2015.06.011zbMath1410.34160OpenAlexW1188656673MaRDI QIDQ1664298

N. A. Almuallem, Ahmed M. Elaiw

Publication date: 24 August 2018

Published in: Applied Mathematics and Computation (Search for Journal in Brave)

Full work available at URL: https://doi.org/10.1016/j.amc.2015.06.011




Related Items (22)

Impact of B-cell impairment on virus dynamics with time delay and two modes of transmissionGlobal stability of discrete pathogen infection model with humoral immunity and cell-to-cell transmissionGlobal properties of saturated chikungunya virus dynamics models with cellular infection and delaysGlobal dynamics of a general diffusive HBV infection model with capsids and adaptive immune responseStability of a discrete-time general delayed viral model with antibody and cell-mediated immune responsesStability of a general HIV-1 reaction-diffusion model with multiple delays and immune responseStability of discrete-time HIV dynamics models with three categories of infected CD \(4^+\) T-cellsStability of a general delay‐distributed virus dynamics model with multi‐staged infected progression and immune responseGLOBAL PROPERTIES OF HIV DYNAMICS MODELS INCLUDING IMPAIRMENT OF B-CELL FUNCTIONSStability of delayed HIV dynamics models with two latent reservoirs and immune impairmentStability of general virus dynamics models with both cellular and viral infectionsGlobal stability of discrete virus dynamics models with humoural immunity and latencyGlobal dynamics of SARS-CoV-2/cancer model with immune responsesGlobal dynamics of reaction-diffusion oncolytic M1 virotherapy with immune responseStability analysis of general humoral immunity HIV dynamics models with discrete delays and HAARTStability of an adaptive immunity viral infection model with multi-stages of infected cells and two routes of infectionGlobal properties of a general latent pathogen dynamics model with delayed pathogenic and cellular infectionsImpact of adaptive immune response and cellular infection on delayed virus dynamics with multi-stages of infected cellsGlobal stability analysis and optimal control of measles model with vaccination and treatmentGlobal stability and optimal control for a hepatitis B virus infection model with immune response and drug therapyStability analysis of a general discrete-time pathogen infection model with humoral immunityGlobal properties of virus dynamics with B-cell impairment



Cites Work




This page was built for publication: Global properties of delayed-HIV dynamics models with differential drug efficacy in cocirculating target cells